CC BY-NC-ND 4.0 · AJP Rep 2024; 14(02): e124-e128
DOI: 10.1055/a-2299-4409
Case Report

Expectant Management of a Triploid Partial Molar Pregnancy at 26 Weeks' Gestation: A Case Report

1   Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2   Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, Canada
,
Mohannad Ali
1   Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2   Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, Canada
,
Marc Stalder
3   Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada
,
Brigitte Bonin
1   Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2   Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, Canada
,
Darine El-Chaâr
1   Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2   Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, Canada
4   School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
5   Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada
› Author Affiliations

Abstract

Introduction Triploid partial molar pregnancies are not viable, and confer maternal risks including preeclampsia, hemorrhage, gestational trophoblastic neoplasia, and trophoblastic embolization. We report a case managed expectantly until 26 weeks' gestation in a patient requesting continuation of pregnancy.

CasePresentation This G2P1 presented with fetal anomalies indicative of triploid partial molar pregnancy. The pregnancy was complicated by anemia, hyperthyroidism, supraventricular tachycardia, and threatened preterm labor.

Her care involved maternal fetal medicine collaborating with internal medicine, palliative care, anesthesia and critical care. Labor was augmented at 26 weeks' gestation, resulting in vaginal delivery. Postpartum course was notably complicated by acute respiratory distress in the immediate postpartum period, which self-resolved. Postpartum hemorrhage and retained products of conception were additional complications.

Conclusion This unique case highlights the role of multidisciplinary collaboration and shared decision making in challenging circumstances.



Publication History

Received: 06 March 2024

Accepted: 27 March 2024

Accepted Manuscript online:
04 April 2024

Article published online:
03 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Kohorn EI. Clinical management and the neoplastic sequelae of trophoblastic embolization associated with hydatidiform mole. Obstet Gynecol Surv 1987; 42 (08) 484-488
  • 2 Prasannan-Nair C, Reynolds SF, Budden G. Partial molar pregnancy with severe pre-eclampsia at 19 weeks' gestation. J Obstet Gynaecol 2006; 26 (08) 817
  • 3 Rahimpanah F, Smoleniec J. Partial mole, triploidy and proteinuric hypertension: two case reports. Aust N Z J Obstet Gynaecol 2000; 40 (02) 215-218
  • 4 Stefos T, Plachouras N, Mari G, Cosmi E, Lolis D. A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks' gestation. Ultrasound Obstet Gynecol 2002; 20 (04) 403-404
  • 5 Drummond S, Fritz E. Management of a partial molar pregnancy: a case study report. J Perinat Neonatal Nurs 2009; 23 (02) 115-123
  • 6 Wing DA, Fassett MJ, Mishell DR. Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial. Obstet Gynecol 2000; 96 (04) 543-548
  • 7 Wang G, Cao J, Xu X, Han X, Cui H. Delivery management of a complete hydatidiform mole and co-existing viable fetus: a meta-analysis and systematic review. J Gynecol Obstet Hum Reprod 2022; 51 (01) 102269
  • 8 Twiggs LB, Phillips GL. Documentation of subclinical trophoblastic embolization with invasive cardiac monitoring in a woman with a molar pregnancy. A case report. J Reprod Med 1986; 31 (04) 277-279
  • 9 Hankins GD, Wendel GD, Snyder RR, Cunningham FG. Trophoblastic embolization during molar evacuation: central hemodynamic observations. Obstet Gynecol 1987; 69 (3 Pt 1): 368-372
  • 10 Rosen T, Sutin K, Carreno CA, Hibbett E, Funai EF. Central hemodynamic monitoring in a woman with acute respiratory insufficiency after evacuation of a complete molar pregnancy. A case report. J Reprod Med 2001; 46 (10) 916-922